Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost-effectiveness analysis.
作者信息
Horton William B, Dart Marina E, Kavuru Varun S, Girton Mark R, Jin Ruyun
机构信息
Division of Endocrinology and Metabolism, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
出版信息
Diabetes Obes Metab. 2024 Nov;26(11):5470-5473. doi: 10.1111/dom.15873. Epub 2024 Aug 19.
PMID:39161067
Abstract
摘要
相似文献
1
Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost-effectiveness analysis.利用利钠肽对2型糖尿病患者进行B期心力衰竭的筛查、诊断与治疗：初步成本效益分析
Diabetes Obes Metab. 2024 Nov;26(11):5470-5473. doi: 10.1111/dom.15873. Epub 2024 Aug 19.
2
[A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients].[一项促进心力衰竭患者合理使用利钠肽检测的全国性运动]
G Ital Cardiol (Rome). 2016 Jan;17(1):48-50. doi: 10.1714/2140.23190.
3
The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective.在初级医疗环境中检测B型利钠肽的成本效益——英国视角
Congest Heart Fail. 2006 Mar-Apr;12(2):103-7. doi: 10.1111/j.1527-5299.2006.04885.x.
4
Natriuretic peptides in screening for cardiac dysfunction.利钠肽在心脏功能障碍筛查中的应用
Heart Fail Clin. 2006 Jul;2(3):323-32. doi: 10.1016/j.hfc.2006.08.007.
5
Cost effectiveness of natriuretic peptide measurement in the primary care setting: have we found the gatekeeper for the evaluation of dyspneic outpatients?在基层医疗环境中测量利钠肽的成本效益：我们是否找到了评估呼吸困难门诊患者的把关指标？
Congest Heart Fail. 2006 Mar-Apr;12(2):108-9. doi: 10.1111/j.1527-5299.2006.05359.x.
6
Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes.实验室和临床中的新兴生物标志物：一种诊断糖尿病心力衰竭的新方法。
J Diabetes Sci Technol. 2024 May;18(3):733-740. doi: 10.1177/19322968241227898. Epub 2024 Jan 31.
7
Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure.糖尿病对B期心力衰竭筛查中利钠肽阈值的影响。
Biomarkers. 2016 Sep;21(6):538-43. doi: 10.3109/1354750X.2016.1160427. Epub 2016 Apr 6.
8
B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.B型利钠肽：是时候将利钠肽纳入我们的临床实践了。
J Cardiovasc Med (Hagerstown). 2006 Jun;7(6):414-5. doi: 10.2459/01.JCM.0000228691.17581.70.
9
Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.利钠肽对急性心力衰竭的诊断准确性：综述。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2415-2420. doi: 10.26355/eurrev_201804_14834.
10
Natriuretic Peptides and Heart Stress: Time to Screen the Asymptomatic High-Risk Population to Prevent Incident Heart Failure?利钠肽与心脏应激：是时候筛查无症状高危人群以预防心力衰竭的发生了吗？
Arq Bras Cardiol. 2024 Aug;121(8):e20230910. doi: 10.36660/abc.20230910.
Zotero 插件